2020 Conference on Retroviruses and Opportunistic Infections*

March 8-11, 2020; Boston, Massachusetts
Review Capsule Summaries, ClinicalThought commentaries, and engaging text dialogue between 2 faculty experts examining the implications of key conference data specifically for European clinicians.
Josep M. Llibre, MD, PhD
Chloe Orkin Photo
Chloe Orkin, MBChB, FRCP, MD
Laura Waters, FRCP, MD

European Perspectives

A long-acting injectable ART option has reached the clinic in Canada and is anticipated to soon be available in other regions of the world. How will this new option and other long-acting strategies coming down the pipeline affect clinical care of our patients with HIV, and what are the specific implications for patient and provider experience in the United Kingdom? Here’s my take.

Chloe Orkin Photo Chloe Orkin, MBChB, FRCP, MD Released: April 6, 2020

It was impossible to miss the impact of COVID-19 on CROI 2020, but what does the emergence of this pandemic mean for our patients living with HIV? Here’s my take based on what I am seeing in Spain.

Josep M. Llibre, MD, PhD Released: April 1, 2020

Experts review new HIV study data on long-acting treatment, switch strategies, care linkage, and coinfection management from CROI 2020 that will affect practice for international clinicians managing HIV patient care around the world.

Josep M. Llibre, MD, PhD Laura Waters, FRCP, MD Released: April 21, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue